STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (Review)

Author： Wang Xiaochun   Crowe Philip J.   Goldstein David   Yang Jia-Lin  

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.41, Iss.4, 2012-10, pp. : 1181-1191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteasome Inhibition: A Novel Approach to Anticancer Therapy

By Paul G. Richardson   Teru Hideshima   Kenneth C. Anderson  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 271-279

Adis International

Access to resources Recommend Favorite

The potential for targeting the STAT3 pathway as a novel therapy for melanoma

By Lesinski Gregory B  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 925-927

Future Medicine

Access to resources Recommend Favorite

STAT3 exon 21 mutation is rare in common human cancers

By Kim Min Sung  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1221-1222

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cells

By          

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 115-121

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells

By Senft Christian   Priester Maike   Polacin Margareth   Schröder Katrin   Seifert Volker   Kögel Donat   Weissenberger Jakob  

Journal of Neuro-Oncology, Vol. 101, Iss. 3, 2011-02 ,pp. : 393-403

Springer Publishing Company

Access to resources Recommend Favorite